img

Global Huntington Disease Protein Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Huntington Disease Protein Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Huntington Disease Protein report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Huntington Disease Protein market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Alzheimer's Disease and Kennedy's Disease are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Huntington Disease Protein industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Huntington Disease Protein key manufacturers include AFFiRiS AG, Ionis Pharmaceuticals, Inc., Neurimmune Holding AG, nLife Therapeutics, S.L., reMYND NV, Sangamo BioSciences, Inc., UniQure N.V., Voyager Therapeutics, Inc. and Vybion, Inc., etc. AFFiRiS AG, Ionis Pharmaceuticals, Inc., Neurimmune Holding AG are top 3 players and held % sales share in total in 2022.
Huntington Disease Protein can be divided into NI-302, NLF-HD, P-301905 and IONIS-HTTRx, etc. NI-302 is the mainstream product in the market, accounting for % sales share globally in 2022.
Huntington Disease Protein is widely used in various fields, such as Alzheimer's Disease, Kennedy's Disease, Spinocerebellar Ataxia and Others, etc. Alzheimer's Disease provides greatest supports to the Huntington Disease Protein industry development. In 2022, global % sales of Huntington Disease Protein went into Alzheimer's Disease filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Huntington Disease Protein market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


AFFiRiS AG
Ionis Pharmaceuticals, Inc.
Neurimmune Holding AG
nLife Therapeutics, S.L.
reMYND NV
Sangamo BioSciences, Inc.
UniQure N.V.
Voyager Therapeutics, Inc.
Vybion, Inc.
WAVE Life Sciences Ltd.
Segment by Type
NI-302
NLF-HD
P-301905
IONIS-HTTRx
Others

Segment by Application


Alzheimer's Disease
Kennedy's Disease
Spinocerebellar Ataxia
Others

Segment by Region


North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Huntington Disease Protein market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Huntington Disease Protein, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Huntington Disease Protein industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Huntington Disease Protein in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Huntington Disease Protein introduction, etc. Huntington Disease Protein Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Huntington Disease Protein market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.

Table of Content

1 Huntington Disease Protein Market Overview
1.1 Huntington Disease Protein Product Overview
1.2 Huntington Disease Protein Market Segment by Type
1.2.1 NI-302
1.2.2 NLF-HD
1.2.3 P-301905
1.2.4 IONIS-HTTRx
1.2.5 Others
1.3 Global Huntington Disease Protein Market Size by Type
1.3.1 Global Huntington Disease Protein Market Size Overview by Type (2018-2034)
1.3.2 Global Huntington Disease Protein Historic Market Size Review by Type (2018-2024)
1.3.3 Global Huntington Disease Protein Forecasted Market Size by Type (2024-2034)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Huntington Disease Protein Sales Breakdown by Type (2018-2024)
1.4.2 Europe Huntington Disease Protein Sales Breakdown by Type (2018-2024)
1.4.3 Asia-Pacific Huntington Disease Protein Sales Breakdown by Type (2018-2024)
1.4.4 Latin America Huntington Disease Protein Sales Breakdown by Type (2018-2024)
1.4.5 Middle East and Africa Huntington Disease Protein Sales Breakdown by Type (2018-2024)
2 Global Huntington Disease Protein Market Competition by Company
2.1 Global Top Players by Huntington Disease Protein Sales (2018-2024)
2.2 Global Top Players by Huntington Disease Protein Revenue (2018-2024)
2.3 Global Top Players by Huntington Disease Protein Price (2018-2024)
2.4 Global Top Manufacturers Huntington Disease Protein Manufacturing Base Distribution, Sales Area, Product Type
2.5 Huntington Disease Protein Market Competitive Situation and Trends
2.5.1 Huntington Disease Protein Market Concentration Rate (2018-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by Huntington Disease Protein Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Huntington Disease Protein as of 2022)
2.7 Date of Key Manufacturers Enter into Huntington Disease Protein Market
2.8 Key Manufacturers Huntington Disease Protein Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Huntington Disease Protein Status and Outlook by Region
3.1 Global Huntington Disease Protein Market Size and CAGR by Region: 2018 VS 2022 VS 2034
3.2 Global Huntington Disease Protein Historic Market Size by Region
3.2.1 Global Huntington Disease Protein Sales in Volume by Region (2018-2024)
3.2.2 Global Huntington Disease Protein Sales in Value by Region (2018-2024)
3.2.3 Global Huntington Disease Protein Sales (Volume & Value) Price and Gross Margin (2018-2024)
3.3 Global Huntington Disease Protein Forecasted Market Size by Region
3.3.1 Global Huntington Disease Protein Sales in Volume by Region (2024-2034)
3.3.2 Global Huntington Disease Protein Sales in Value by Region (2024-2034)
3.3.3 Global Huntington Disease Protein Sales (Volume & Value), Price and Gross Margin (2024-2034)
4 Global Huntington Disease Protein by Application
4.1 Huntington Disease Protein Market Segment by Application
4.1.1 Alzheimer's Disease
4.1.2 Kennedy's Disease
4.1.3 Spinocerebellar Ataxia
4.1.4 Others
4.2 Global Huntington Disease Protein Market Size by Application
4.2.1 Global Huntington Disease Protein Market Size Overview by Application (2018-2034)
4.2.2 Global Huntington Disease Protein Historic Market Size Review by Application (2018-2024)
4.2.3 Global Huntington Disease Protein Forecasted Market Size by Application (2024-2034)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Huntington Disease Protein Sales Breakdown by Application (2018-2024)
4.3.2 Europe Huntington Disease Protein Sales Breakdown by Application (2018-2024)
4.3.3 Asia-Pacific Huntington Disease Protein Sales Breakdown by Application (2018-2024)
4.3.4 Latin America Huntington Disease Protein Sales Breakdown by Application (2018-2024)
4.3.5 Middle East and Africa Huntington Disease Protein Sales Breakdown by Application (2018-2024)
5 North America Huntington Disease Protein by Country
5.1 North America Huntington Disease Protein Historic Market Size by Country
5.1.1 North America Huntington Disease Protein Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
5.1.2 North America Huntington Disease Protein Sales in Volume by Country (2018-2024)
5.1.3 North America Huntington Disease Protein Sales in Value by Country (2018-2024)
5.2 North America Huntington Disease Protein Forecasted Market Size by Country
5.2.1 North America Huntington Disease Protein Sales in Volume by Country (2024-2034)
5.2.2 North America Huntington Disease Protein Sales in Value by Country (2024-2034)
6 Europe Huntington Disease Protein by Country
6.1 Europe Huntington Disease Protein Historic Market Size by Country
6.1.1 Europe Huntington Disease Protein Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
6.1.2 Europe Huntington Disease Protein Sales in Volume by Country (2018-2024)
6.1.3 Europe Huntington Disease Protein Sales in Value by Country (2018-2024)
6.2 Europe Huntington Disease Protein Forecasted Market Size by Country
6.2.1 Europe Huntington Disease Protein Sales in Volume by Country (2024-2034)
6.2.2 Europe Huntington Disease Protein Sales in Value by Country (2024-2034)
7 Asia-Pacific Huntington Disease Protein by Region
7.1 Asia-Pacific Huntington Disease Protein Historic Market Size by Region
7.1.1 Asia-Pacific Huntington Disease Protein Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2034
7.1.2 Asia-Pacific Huntington Disease Protein Sales in Volume by Region (2018-2024)
7.1.3 Asia-Pacific Huntington Disease Protein Sales in Value by Region (2018-2024)
7.2 Asia-Pacific Huntington Disease Protein Forecasted Market Size by Region
7.2.1 Asia-Pacific Huntington Disease Protein Sales in Volume by Region (2024-2034)
7.2.2 Asia-Pacific Huntington Disease Protein Sales in Value by Region (2024-2034)
8 Latin America Huntington Disease Protein by Country
8.1 Latin America Huntington Disease Protein Historic Market Size by Country
8.1.1 Latin America Huntington Disease Protein Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
8.1.2 Latin America Huntington Disease Protein Sales in Volume by Country (2018-2024)
8.1.3 Latin America Huntington Disease Protein Sales in Value by Country (2018-2024)
8.2 Latin America Huntington Disease Protein Forecasted Market Size by Country
8.2.1 Latin America Huntington Disease Protein Sales in Volume by Country (2024-2034)
8.2.2 Latin America Huntington Disease Protein Sales in Value by Country (2024-2034)
9 Middle East and Africa Huntington Disease Protein by Country
9.1 Middle East and Africa Huntington Disease Protein Historic Market Size by Country
9.1.1 Middle East and Africa Huntington Disease Protein Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
9.1.2 Middle East and Africa Huntington Disease Protein Sales in Volume by Country (2018-2024)
9.1.3 Middle East and Africa Huntington Disease Protein Sales in Value by Country (2018-2024)
9.2 Middle East and Africa Huntington Disease Protein Forecasted Market Size by Country
9.2.1 Middle East and Africa Huntington Disease Protein Sales in Volume by Country (2024-2034)
9.2.2 Middle East and Africa Huntington Disease Protein Sales in Value by Country (2024-2034)
10 Company Profiles
10.1 AFFiRiS AG
10.1.1 AFFiRiS AG Company Information
10.1.2 AFFiRiS AG Introduction and Business Overview
10.1.3 AFFiRiS AG Huntington Disease Protein Sales, Revenue and Gross Margin (2018-2024)
10.1.4 AFFiRiS AG Huntington Disease Protein Products Offered
10.1.5 AFFiRiS AG Recent Development
10.2 Ionis Pharmaceuticals, Inc.
10.2.1 Ionis Pharmaceuticals, Inc. Company Information
10.2.2 Ionis Pharmaceuticals, Inc. Introduction and Business Overview
10.2.3 Ionis Pharmaceuticals, Inc. Huntington Disease Protein Sales, Revenue and Gross Margin (2018-2024)
10.2.4 Ionis Pharmaceuticals, Inc. Huntington Disease Protein Products Offered
10.2.5 Ionis Pharmaceuticals, Inc. Recent Development
10.3 Neurimmune Holding AG
10.3.1 Neurimmune Holding AG Company Information
10.3.2 Neurimmune Holding AG Introduction and Business Overview
10.3.3 Neurimmune Holding AG Huntington Disease Protein Sales, Revenue and Gross Margin (2018-2024)
10.3.4 Neurimmune Holding AG Huntington Disease Protein Products Offered
10.3.5 Neurimmune Holding AG Recent Development
10.4 nLife Therapeutics, S.L.
10.4.1 nLife Therapeutics, S.L. Company Information
10.4.2 nLife Therapeutics, S.L. Introduction and Business Overview
10.4.3 nLife Therapeutics, S.L. Huntington Disease Protein Sales, Revenue and Gross Margin (2018-2024)
10.4.4 nLife Therapeutics, S.L. Huntington Disease Protein Products Offered
10.4.5 nLife Therapeutics, S.L. Recent Development
10.5 reMYND NV
10.5.1 reMYND NV Company Information
10.5.2 reMYND NV Introduction and Business Overview
10.5.3 reMYND NV Huntington Disease Protein Sales, Revenue and Gross Margin (2018-2024)
10.5.4 reMYND NV Huntington Disease Protein Products Offered
10.5.5 reMYND NV Recent Development
10.6 Sangamo BioSciences, Inc.
10.6.1 Sangamo BioSciences, Inc. Company Information
10.6.2 Sangamo BioSciences, Inc. Introduction and Business Overview
10.6.3 Sangamo BioSciences, Inc. Huntington Disease Protein Sales, Revenue and Gross Margin (2018-2024)
10.6.4 Sangamo BioSciences, Inc. Huntington Disease Protein Products Offered
10.6.5 Sangamo BioSciences, Inc. Recent Development
10.7 UniQure N.V.
10.7.1 UniQure N.V. Company Information
10.7.2 UniQure N.V. Introduction and Business Overview
10.7.3 UniQure N.V. Huntington Disease Protein Sales, Revenue and Gross Margin (2018-2024)
10.7.4 UniQure N.V. Huntington Disease Protein Products Offered
10.7.5 UniQure N.V. Recent Development
10.8 Voyager Therapeutics, Inc.
10.8.1 Voyager Therapeutics, Inc. Company Information
10.8.2 Voyager Therapeutics, Inc. Introduction and Business Overview
10.8.3 Voyager Therapeutics, Inc. Huntington Disease Protein Sales, Revenue and Gross Margin (2018-2024)
10.8.4 Voyager Therapeutics, Inc. Huntington Disease Protein Products Offered
10.8.5 Voyager Therapeutics, Inc. Recent Development
10.9 Vybion, Inc.
10.9.1 Vybion, Inc. Company Information
10.9.2 Vybion, Inc. Introduction and Business Overview
10.9.3 Vybion, Inc. Huntington Disease Protein Sales, Revenue and Gross Margin (2018-2024)
10.9.4 Vybion, Inc. Huntington Disease Protein Products Offered
10.9.5 Vybion, Inc. Recent Development
10.10 WAVE Life Sciences Ltd.
10.10.1 WAVE Life Sciences Ltd. Company Information
10.10.2 WAVE Life Sciences Ltd. Introduction and Business Overview
10.10.3 WAVE Life Sciences Ltd. Huntington Disease Protein Sales, Revenue and Gross Margin (2018-2024)
10.10.4 WAVE Life Sciences Ltd. Huntington Disease Protein Products Offered
10.10.5 WAVE Life Sciences Ltd. Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Huntington Disease Protein Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Huntington Disease Protein Industrial Chain Analysis
11.4 Huntington Disease Protein Market Dynamics
11.4.1 Huntington Disease Protein Industry Trends
11.4.2 Huntington Disease Protein Market Drivers
11.4.3 Huntington Disease Protein Market Challenges
11.4.4 Huntington Disease Protein Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Huntington Disease Protein Distributors
12.3 Huntington Disease Protein Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of NI-302
Table 2. Major Company of NLF-HD
Table 3. Major Company of P-301905
Table 4. Major Company of IONIS-HTTRx
Table 5. Major Company of Others
Table 6. Global Huntington Disease Protein Sales by Type 2018 VS 2022 VS 2034 (US$ Million)
Table 7. Global Huntington Disease Protein Sales by Type (2018-2024) & (K Pcs)
Table 8. Global Huntington Disease Protein Sales Market Share in Volume by Type (2018-2024)
Table 9. Global Huntington Disease Protein Sales by Type (2018-2024) & (US& Million)
Table 10. Global Huntington Disease Protein Market Share in Value by Type (2018-2024)
Table 11. Global Huntington Disease Protein Price by Type (2018-2024) & (USD/Pcs)
Table 12. Global Huntington Disease Protein Sales by Type (2024-2034) & (K Pcs)
Table 13. Global Huntington Disease Protein Sales Market Share in Volume by Type (2024-2034)
Table 14. Global Huntington Disease Protein Sales by Type (2024-2034) & (US$ Million)
Table 15. Global Huntington Disease Protein Sales Market Share in Value by Type (2024-2034)
Table 16. Global Huntington Disease Protein Price by Type (2024-2034) & (USD/Pcs)
Table 17. North America Huntington Disease Protein Sales by Type (2018-2024) & (K Pcs)
Table 18. North America Huntington Disease Protein Sales by Type (2018-2024) & (US$ Million)
Table 19. Europe Huntington Disease Protein Sales (K Pcs) by Type (2018-2024)
Table 20. Europe Huntington Disease Protein Sales by Type (2018-2024) & (US$ Million)
Table 21. Asia-Pacific Huntington Disease Protein Sales (K Pcs) by Type (2018-2024)
Table 22. Asia-Pacific Huntington Disease Protein Sales by Type (2018-2024) & (US$ Million)
Table 23. Latin America Huntington Disease Protein Sales (K Pcs) by Type (2018-2024)
Table 24. Latin America Huntington Disease Protein Sales by Type (2018-2024) & (US$ Million)
Table 25. Middle East and Africa Huntington Disease Protein Sales (K Pcs) by Type (2018-2024)
Table 26. Middle East and Africa Huntington Disease Protein Sales by Type (2018-2024) & (US$ Million)
Table 27. Global Huntington Disease Protein Sales by Company (2018-2024) & (K Pcs)
Table 28. Global Huntington Disease Protein Sales Share by Company (2018-2024)
Table 29. Global Huntington Disease Protein Revenue by Company (2018-2024) & (US$ Million)
Table 30. Global Huntington Disease Protein Revenue Share by Company (2018-2024)
Table 31. Global Market Huntington Disease Protein Price by Company (2018-2024) & (USD/Pcs)
Table 32. Global Huntington Disease Protein Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 33. Global Huntington Disease Protein Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 34. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Huntington Disease Protein as of 2022)
Table 35. Date of Key Manufacturers Enter into Huntington Disease Protein Market
Table 36. Key Manufacturers Huntington Disease Protein Product Type
Table 37. Mergers & Acquisitions, Expansion Plans
Table 38. Global Huntington Disease Protein Market Size Comparison by Region (US$ Million): 2018 VS 2022 VS 2034
Table 39. Global Huntington Disease Protein Sales by Region (2018-2024) & (K Pcs)
Table 40. Global Huntington Disease Protein Sales Market Share in Volume by Region (2018-2024)
Table 41. Global Huntington Disease Protein Sales by Region (2018-2024) & (US$ Million)
Table 42. Global Huntington Disease Protein Sales Market Share in Value by Region (2018-2024)
Table 43. Global Huntington Disease Protein Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 44. Global Huntington Disease Protein Sales by Region (2024-2034) & (K Pcs)
Table 45. Global Huntington Disease Protein Sales Market Share in Volume by Region (2024-2034)
Table 46. Global Huntington Disease Protein Sales by Region (2024-2034) & (US$ Million)
Table 47. Global Huntington Disease Protein Sales Market Share in Value by Region (2024-2034)
Table 48. Global Huntington Disease Protein Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2024-2034)
Table 49. Global Huntington Disease Protein Sales by Application: 2018 VS 2022 VS 2034 (US$ Million)
Table 50. Global Huntington Disease Protein Sales by Application (2018-2024) & (K Pcs)
Table 51. Global Huntington Disease Protein Sales Market Share in Volume by Application (2018-2024)
Table 52. Global Huntington Disease Protein Sales by Application (2018-2024) & (US$ Million)
Table 53. Global Huntington Disease Protein Sales Market Share in Value by Application (2018-2024)
Table 54. Global Huntington Disease Protein Price by Application (2018-2024) & (USD/Pcs)
Table 55. Global Huntington Disease Protein Sales by Application (2024-2034) & (K Pcs)
Table 56. Global Huntington Disease Protein Sales Market Share in Volume by Application (2024-2034)
Table 57. Global Huntington Disease Protein Sales by Application (2024-2034) & (US$ Million)
Table 58. Global Huntington Disease Protein Sales Market Share in Value by Application (2024-2034)
Table 59. Global Huntington Disease Protein Price by Application (2024-2034) & (USD/Pcs)
Table 60. North America Huntington Disease Protein Sales by Application (2018-2024) (K Pcs)
Table 61. North America Huntington Disease Protein Sales by Application (2018-2024) & (US$ Million)
Table 62. Europe Huntington Disease Protein Sales by Application (2018-2024) (K Pcs)
Table 63. Europe Huntington Disease Protein Sales by Application (2018-2024) & (US$ Million)
Table 64. Asia-Pacific Huntington Disease Protein Sales by Application (2018-2024) (K Pcs)
Table 65. Asia-Pacific Huntington Disease Protein Sales by Application (2018-2024) & (US$ Million)
Table 66. Latin America Huntington Disease Protein Sales by Application (2018-2024) (K Pcs)
Table 67. Latin America Huntington Disease Protein Sales by Application (2018-2024) & (US$ Million)
Table 68. Middle East and Africa Huntington Disease Protein Sales by Application (2018-2024) (K Pcs)
Table 69. Middle East and Africa Huntington Disease Protein Sales by Application (2018-2024) & (US$ Million)
Table 70. North America Huntington Disease Protein Sales by Country (2018-2024) & (K Pcs)
Table 71. North America Huntington Disease Protein Sales Market Share in Volume by Country (2018-2024)
Table 72. North America Huntington Disease Protein Sales by Country (2018-2024) & (US$ Million)
Table 73. North America Huntington Disease Protein Sales Market Share in Value by Country (2018-2024)
Table 74. North America Huntington Disease Protein Sales by Country (2024-2034) & (K Pcs)
Table 75. North America Huntington Disease Protein Sales Market Share in Volume by Country (2024-2034)
Table 76. North America Huntington Disease Protein Sales by Country (2024-2034) & (US$ Million)
Table 77. North America Huntington Disease Protein Sales Market Share in Value by Country (2024-2034)
Table 78. Europe Huntington Disease Protein Sales by Country (2018-2024) & (K Pcs)
Table 79. Europe Huntington Disease Protein Sales Market Share in Volume by Country (2018-2024)
Table 80. Europe Huntington Disease Protein Sales by Country (2018-2024) & (US$ Million)
Table 81. Europe Huntington Disease Protein Sales Market Share in Value by Country (2018-2024)
Table 82. Europe Huntington Disease Protein Sales by Country (2024-2034) & (K Pcs)
Table 83. Europe Huntington Disease Protein Sales Market Share in Volume by Country (2024-2034)
Table 84. Europe Huntington Disease Protein Sales by Country (2024-2034) & (US$ Million)
Table 85. Europe Huntington Disease Protein Sales Market Share in Value by Country (2024-2034)
Table 86. Asia-Pacific Huntington Disease Protein Sales by Region (2018-2024) & (K Pcs)
Table 87. Asia-Pacific Huntington Disease Protein Sales Market Share in Volume by Region (2018-2024)
Table 88. Asia-Pacific Huntington Disease Protein Sales by Region (2018-2024) & (US$ Million)
Table 89. Asia-Pacific Huntington Disease Protein Sales Market Share in Value by Region (2018-2024)
Table 90. Asia-Pacific Huntington Disease Protein Sales by Region (2024-2034) & (K Pcs)
Table 91. Asia-Pacific Huntington Disease Protein Sales Market Share in Volume by Region (2024-2034)
Table 92. Asia-Pacific Huntington Disease Protein Sales by Region (2024-2034) & (US$ Million)
Table 93. Asia-Pacific Huntington Disease Protein Sales Market Share in Value by Region (2024-2034)
Table 94. Latin America Huntington Disease Protein Sales by Country (2018-2024) & (K Pcs)
Table 95. Latin America Huntington Disease Protein Sales Market Share in Volume by Country (2018-2024)
Table 96. Latin America Huntington Disease Protein Sales by Country (2018-2024) & (US$ Million)
Table 97. Latin America Huntington Disease Protein Sales Market Share in Value by Country (2018-2024)
Table 98. Latin America Huntington Disease Protein Sales by Country (2024-2034) & (K Pcs)
Table 99. Latin America Huntington Disease Protein Sales Market Share in Volume by Country (2024-2034)
Table 100. Latin America Huntington Disease Protein Sales by Country (2024-2034) & (US$ Million)
Table 101. Latin America Huntington Disease Protein Sales Market Share in Value by Country (2024-2034)
Table 102. Middle East and Africa Huntington Disease Protein Sales by Country (2018-2024) & (K Pcs)
Table 103. Middle East and Africa Huntington Disease Protein Sales Market Share in Volume by Country (2018-2024)
Table 104. Middle East and Africa Huntington Disease Protein Sales by Country (2018-2024) & (US$ Million)
Table 105. Middle East and Africa Huntington Disease Protein Sales Market Share in Value by Country (2018-2024)
Table 106. Middle East and Africa Huntington Disease Protein Sales by Country (2024-2034) & (K Pcs)
Table 107. Middle East and Africa Huntington Disease Protein Sales Market Share in Volume by Country (2024-2034)
Table 108. Middle East and Africa Huntington Disease Protein Sales by Country (2024-2034) & (US$ Million)
Table 109. Middle East and Africa Huntington Disease Protein Sales Market Share in Value by Country (2024-2034)
Table 110. AFFiRiS AG Company Information
Table 111. AFFiRiS AG Introduction and Business Overview
Table 112. AFFiRiS AG Huntington Disease Protein Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 113. AFFiRiS AG Huntington Disease Protein Product
Table 114. AFFiRiS AG Recent Development
Table 115. Ionis Pharmaceuticals, Inc. Company Information
Table 116. Ionis Pharmaceuticals, Inc. Introduction and Business Overview
Table 117. Ionis Pharmaceuticals, Inc. Huntington Disease Protein Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 118. Ionis Pharmaceuticals, Inc. Huntington Disease Protein Product
Table 119. Ionis Pharmaceuticals, Inc. Recent Development
Table 120. Neurimmune Holding AG Company Information
Table 121. Neurimmune Holding AG Introduction and Business Overview
Table 122. Neurimmune Holding AG Huntington Disease Protein Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 123. Neurimmune Holding AG Huntington Disease Protein Product
Table 124. Neurimmune Holding AG Recent Development
Table 125. nLife Therapeutics, S.L. Company Information
Table 126. nLife Therapeutics, S.L. Introduction and Business Overview
Table 127. nLife Therapeutics, S.L. Huntington Disease Protein Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 128. nLife Therapeutics, S.L. Huntington Disease Protein Product
Table 129. nLife Therapeutics, S.L. Recent Development
Table 130. reMYND NV Company Information
Table 131. reMYND NV Introduction and Business Overview
Table 132. reMYND NV Huntington Disease Protein Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 133. reMYND NV Huntington Disease Protein Product
Table 134. reMYND NV Recent Development
Table 135. Sangamo BioSciences, Inc. Company Information
Table 136. Sangamo BioSciences, Inc. Introduction and Business Overview
Table 137. Sangamo BioSciences, Inc. Huntington Disease Protein Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 138. Sangamo BioSciences, Inc. Huntington Disease Protein Product
Table 139. Sangamo BioSciences, Inc. Recent Development
Table 140. UniQure N.V. Company Information
Table 141. UniQure N.V. Introduction and Business Overview
Table 142. UniQure N.V. Huntington Disease Protein Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 143. UniQure N.V. Huntington Disease Protein Product
Table 144. UniQure N.V. Recent Development
Table 145. Voyager Therapeutics, Inc. Company Information
Table 146. Voyager Therapeutics, Inc. Introduction and Business Overview
Table 147. Voyager Therapeutics, Inc. Huntington Disease Protein Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 148. Voyager Therapeutics, Inc. Huntington Disease Protein Product
Table 149. Voyager Therapeutics, Inc. Recent Development
Table 150. Vybion, Inc. Company Information
Table 151. Vybion, Inc. Introduction and Business Overview
Table 152. Vybion, Inc. Huntington Disease Protein Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 153. Vybion, Inc. Huntington Disease Protein Product
Table 154. Vybion, Inc. Recent Development
Table 155. WAVE Life Sciences Ltd. Company Information
Table 156. WAVE Life Sciences Ltd. Introduction and Business Overview
Table 157. WAVE Life Sciences Ltd. Huntington Disease Protein Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 158. WAVE Life Sciences Ltd. Huntington Disease Protein Product
Table 159. WAVE Life Sciences Ltd. Recent Development
Table 160. Key Raw Materials Lists
Table 161. Raw Materials Key Suppliers Lists
Table 162. Huntington Disease Protein Market Trends
Table 163. Huntington Disease Protein Market Drivers
Table 164. Huntington Disease Protein Market Challenges
Table 165. Huntington Disease Protein Market Restraints
Table 166. Huntington Disease Protein Distributors List
Table 167. Huntington Disease Protein Downstream Customers
Table 168. Research Programs/Design for This Report
Table 169. Key Data Information from Secondary Sources
Table 170. Key Data Information from Primary Sources
List of Figures
Figure 1. Huntington Disease Protein Product Picture
Figure 2. Global Huntington Disease Protein Market Size, 2018 VS 2022 VS 2034 (US$ Million)
Figure 3. Global Huntington Disease Protein Market Size Status and Outlook (2018-2034) & (US$ Million)
Figure 4. Global Huntington Disease Protein Sales Status and Outlook (2018-2034) & (K Pcs)
Figure 5. Product Picture of NI-302
Figure 6. Global NI-302 Sales YoY Growth (2018-2034) & (K Pcs)
Figure 7. Product Picture of NLF-HD
Figure 8. Global NLF-HD Sales YoY Growth (2018-2034) & (K Pcs)
Figure 9. Product Picture of P-301905
Figure 10. Global P-301905 Sales YoY Growth (2018-2034) & (K Pcs)
Figure 11. Product Picture of IONIS-HTTRx
Figure 12. Global IONIS-HTTRx Sales YoY Growth (2018-2034) & (K Pcs)
Figure 13. Product Picture of Others
Figure 14. Global Others Sales YoY Growth (2018-2034) & (K Pcs)
Figure 15. Global Huntington Disease Protein Sales by Type (2018-2034) & (US$ Million)
Figure 16. Global Huntington Disease Protein Sales Market Share by Type in 2022 & 2034
Figure 17. North America Huntington Disease Protein Sales Market Share in Volume by Type in 2022
Figure 18. North America Huntington Disease Protein Sales Market Share in Value by Type in 2022
Figure 19. Europe Huntington Disease Protein Sales Market Share in Volume by Type in 2022
Figure 20. Europe Huntington Disease Protein Sales Market Share in Value by Type in 2022
Figure 21. Asia-Pacific Huntington Disease Protein Sales Market Share in Volume by Type in 2022
Figure 22. Asia-Pacific Huntington Disease Protein Sales Market Share in Value by Type in 2022
Figure 23. Latin America Huntington Disease Protein Sales Market Share in Volume by Type in 2022
Figure 24. Latin America Huntington Disease Protein Sales Market Share in Value by Type in 2022
Figure 25. Middle East and Africa Huntington Disease Protein Sales Market Share in Volume by Type in 2022
Figure 26. Middle East and Africa Huntington Disease Protein Sales Market Share in Value by Type in 2022
Figure 27. The 5 and 10 Largest Manufacturers in the World: Market Share by Huntington Disease Protein Sales in 2022
Figure 28. The 5 and 10 Largest Manufacturers in the World: Market Share by Huntington Disease Protein Revenue in 2022
Figure 29. Huntington Disease Protein Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 30. Product Picture of Alzheimer's Disease
Figure 31. Global Alzheimer's Disease Sales YoY Growth (2018-2034) & (K Pcs)
Figure 32. Product Picture of Kennedy's Disease
Figure 33. Global Kennedy's Disease Sales YoY Growth (2018-2034) & (K Pcs)
Figure 34. Product Picture of Spinocerebellar Ataxia
Figure 35. Global Spinocerebellar Ataxia Sales YoY Growth (2018-2034) & (K Pcs)
Figure 36. Product Picture of Others
Figure 37. Global Others Sales YoY Growth (2018-2034) & (K Pcs)
Figure 38. Global Huntington Disease Protein Sales by Application (2018-2034) & (US$ Million)
Figure 39. Global Huntington Disease Protein Sales Market Share by Application in 2022 & 2034
Figure 40. North America Huntington Disease Protein Sales Market Share in Volume by Application in 2022
Figure 41. North America Huntington Disease Protein Sales Market Share in Value by Application in 2022
Figure 42. Europe Huntington Disease Protein Sales Market Share in Volume by Application in 2022
Figure 43. Europe Huntington Disease Protein Sales Market Share in Value by Application in 2022
Figure 44. Asia-Pacific Huntington Disease Protein Sales Market Share in Volume by Application in 2022
Figure 45. Asia-Pacific Huntington Disease Protein Sales Market Share in Value by Application in 2022
Figure 46. Latin America Huntington Disease Protein Sales Market Share in Volume by Application in 2022
Figure 47. Latin America Huntington Disease Protein Sales Market Share in Value by Application in 2022
Figure 48. Middle East and Africa Huntington Disease Protein Sales Market Share in Value by Application in 2022
Figure 49. Key Raw Materials Price
Figure 50. Huntington Disease Protein Manufacturing Cost Structure
Figure 51. Huntington Disease Protein Industrial Chain Analysis
Figure 52. Channels of Distribution
Figure 53. Distributors Profiles
Figure 54. Bottom-up and Top-down Approaches for This Report
Figure 55. Data Triangulation
Figure 56. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries